Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Profit After Tax (2023 - 2025)

Xenetic Biosciences' Profit After Tax history spans 7 years, with the latest figure at -$579076.0 for Q4 2025.

  • For Q4 2025, Profit After Tax rose 45.09% year-over-year to -$579076.0; the TTM value through Dec 2025 reached -$2.7 million, up 32.31%, while the annual FY2025 figure was -$2.7 million, 32.31% up from the prior year.
  • Profit After Tax reached -$579076.0 in Q4 2025 per XBIO's latest filing, down from -$509940.0 in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$436671.0 in Q3 2024 to a low of -$1.3 million in Q2 2024.
  • Average Profit After Tax over 3 years is -$897976.1, with a median of -$977052.0 recorded in 2023.
  • The largest YoY upside for Profit After Tax was 58.63% in 2024 against a maximum downside of 39.53% in 2024.
  • A 3-year view of Profit After Tax shows it stood at -$1.2 million in 2023, then grew by 9.99% to -$1.1 million in 2024, then soared by 45.09% to -$579076.0 in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Profit After Tax are -$579076.0 (Q4 2025), -$509940.0 (Q3 2025), and -$688703.0 (Q2 2025).